Ftse Mib
37.184,55
0,35%
DAX
21.925,56
0,75%
S&P 500
6.065,45
0,65%
NASDAQ
19.755,69
1,19%
Bitcoin
97.183,62
0,72%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Relay Therapeutics Inc (RLAY) Relay Therapeutics Inc (RLAY) Notizie

Relay Therapeutics Inc

RLAY
4,135
-0,085 (-2,01%)
Ultimo aggiornamento: 16:51:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/2/202519:23EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
31/1/202503:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202503:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/1/202522:03EDGAR2Form 144 - Report of proposed sale of securities
28/1/202522:48EDGAR2Form 144 - Report of proposed sale of securities
24/1/202501:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202522:03EDGAR2Form 144 - Report of proposed sale of securities
22/1/202522:04EDGAR2Form 144 - Report of proposed sale of securities
21/1/202522:08EDGAR2Form 144 - Report of proposed sale of securities
15/1/202503:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202503:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202503:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202514:30EDGAR2Form 8-K - Current report
07/1/202522:05GLOBERelay Therapeutics to Present at 43rd Annual J.P. Morgan..
07/1/202502:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:05EDGAR2Form 144 - Report of proposed sale of securities
31/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202422:01EDGAR2Form 144 - Report of proposed sale of securities
18/12/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:18EDGAR2Form 144 - Report of proposed sale of securities
11/12/202413:00EDGAR2Form 8-K - Current report
11/12/202412:00GLOBERelay Therapeutics Announces Updated Interim Data for..
09/12/202422:05GLOBERelay Therapeutics to Present Updated Clinical Data on..
03/12/202414:01GLOBEElevar Therapeutics and Relay Therapeutics Announce..
03/12/202414:00GLOBERelay Therapeutics and Elevar Therapeutics Announce..
07/11/202422:05GLOBERelay Therapeutics to Participate in Upcoming Investor..
06/11/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:10EDGAR2Form 8-K - Current report
06/11/202422:05GLOBERelay Therapeutics Reports Third Quarter 2024 Financial..
30/10/202421:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202421:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202421:05GLOBERelay Therapeutics to Announce Third Quarter 2024 Financial..
29/10/202421:04EDGAR2Form 144 - Report of proposed sale of securities
28/10/202421:05EDGAR2Form 144 - Report of proposed sale of securities
01/10/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:27EDGAR2Form 144 - Report of proposed sale of securities
11/9/202422:49EDGAR2Form 8-K - Current report
11/9/202422:45EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/9/202402:21GLOBERelay Therapeutics Announces Pricing of Public Offering of..
09/9/202422:43EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/9/202422:34GLOBERelay Therapeutics Announces Proposed Public Offering of..
09/9/202414:00EDGAR2Form 8-K - Current report
09/9/202412:55GLOBERelay Therapeutics Announces Positive Interim Data for..
06/9/202422:05GLOBERelay Therapeutics Announces Webcast to Report RLY-2608 Data..
06/8/202423:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
06/8/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:10EDGAR2Form 8-K - Current report
06/8/202422:05GLOBERelay Therapeutics Reports Second Quarter 2024 Financial..
Apertura: 4,21 Min: 4,07 Max: 4,21
Chiusura: 4,22

La tua Cronologia

NASDAQ
RLAY
Relay Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci